News Genpact finds $18tn in trapped AI value Genpact and analyst firm HFS Research recently published a new global study identifying four enterprise debts.
Market Access Capital discipline in biotech: Building enduring companies w... Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.
R&D Sponsored A New Framework to Engineer Breakthrough Value for Medicines A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.
Digital From pilots to impact: What it really takes to scale GenAI i... It’s no longer about what GenAI can do. It’s about what it should do – and whether it can consistently deliver value at scale.
Digital Balancing innovation and implementation: Embracing agentic A... A three-stage framework guides organisations through their agentic AI journey, ensuring effective ecosystem development.
Digital A well-kept secret: Applying IEPs to accelerate digital heal... Akira Endo discovered mevastatin, a cholesterol-lowering breakthrough molecule in 1973.
News Hengrui gets world-first okay for platelet drug hetrombopag Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
